$NKTX
Nkarta Inc

2023 Q3 Form 10-Q Financial Statement

#000095017023040953 Filed on August 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $7.100M $7.636M
YoY Change 4.0% 16.35%
% of Gross Profit
Research & Development $22.19M $25.12M
YoY Change -5.3% 19.35%
% of Gross Profit
Depreciation & Amortization $2.000M $800.0K
YoY Change 185.71% 33.33%
% of Gross Profit
Operating Expenses $29.29M $36.86M
YoY Change -3.2% 33.49%
Operating Profit -$29.29M -$36.86M
YoY Change -3.2% 33.49%
Interest Expense $3.620M $3.570M
YoY Change 90.53% 420.41%
% of Operating Profit
Other Income/Expense, Net $3.649M $3.571M
YoY Change 90.35% 418.29%
Pretax Income -$25.65M -$33.29M
YoY Change -9.51% 23.64%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$25.65M -$33.29M
YoY Change -9.53% 23.64%
Net Earnings / Revenue
Basic Earnings Per Share -$0.52 -$0.68
Diluted Earnings Per Share -$0.52 -$0.68
COMMON SHARES
Basic Shares Outstanding 49.06M 48.93M
Diluted Shares Outstanding 49.06M 48.97M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $275.6M $280.8M
YoY Change -29.76% -32.01%
Cash & Equivalents $38.26M $29.12M
Short-Term Investments $237.4M $251.6M
Other Short-Term Assets $1.589M $2.593M
YoY Change -53.71% 24.36%
Inventory
Prepaid Expenses $3.986M $3.390M
Receivables
Other Receivables
Total Short-Term Assets $281.2M $286.7M
YoY Change -29.86% -31.3%
LONG-TERM ASSETS
Property, Plant & Equipment $77.69M $76.09M
YoY Change 156.83% 349.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $18.73M
YoY Change
Other Assets $3.727M $3.666M
YoY Change 94.22% 206.78%
Total Long-Term Assets $124.7M $142.3M
YoY Change 21.18% 64.96%
TOTAL ASSETS
Total Short-Term Assets $281.2M $286.7M
Total Long-Term Assets $124.7M $142.3M
Total Assets $405.9M $429.0M
YoY Change -19.44% -14.81%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.284M $3.010M
YoY Change -54.88% 1.42%
Accrued Expenses $15.30M $17.55M
YoY Change 32.24% 145.67%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $25.64M $26.61M
YoY Change -2.97% 101.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $83.40M $84.45M
YoY Change 1667900.0% 1055487.5%
Total Long-Term Liabilities $83.40M $84.45M
YoY Change 1667900.0% 1055487.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.64M $26.61M
Total Long-Term Liabilities $83.40M $84.45M
Total Liabilities $109.0M $111.1M
YoY Change 4.32% 34.46%
SHAREHOLDERS EQUITY
Retained Earnings -$407.7M -$382.0M
YoY Change 42.85% 48.64%
Common Stock $704.9M $700.6M
YoY Change 2.77% 3.19%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $296.8M $318.0M
YoY Change
Total Liabilities & Shareholders Equity $405.9M $429.0M
YoY Change -19.44% -14.81%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$25.65M -$33.29M
YoY Change -9.53% 23.64%
Depreciation, Depletion And Amortization $2.000M $800.0K
YoY Change 185.71% 33.33%
Cash From Operating Activities -$20.28M -$21.77M
YoY Change 37.05% 31.05%
INVESTING ACTIVITIES
Capital Expenditures $6.190M $10.33M
YoY Change -180.66% -492.85%
Acquisitions
YoY Change
Other Investing Activities $35.61M $7.157M
YoY Change -149.85% -106.71%
Cash From Investing Activities $29.42M -$3.171M
YoY Change -137.19% -97.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 395.0K
YoY Change -100.0% -99.82%
NET CHANGE
Cash From Operating Activities -20.28M -21.77M
Cash From Investing Activities 29.42M -3.171M
Cash From Financing Activities 0.000 395.0K
Net Change In Cash 9.140M -24.55M
YoY Change -110.01% -127.27%
FREE CASH FLOW
Cash From Operating Activities -$20.28M -$21.77M
Capital Expenditures $6.190M $10.33M
Free Cash Flow -$26.47M -$32.10M
YoY Change 271.61% 129.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001787400
dei Amendment Flag
AmendmentFlag
false
CY2023Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39370
dei Entity Registrant Name
EntityRegistrantName
Nkarta, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-4515206
dei Entity Address Address Line1
EntityAddressAddressLine1
1150 Veterans Boulevard
dei Entity Address City Or Town
EntityAddressCityOrTown
South San Francisco
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94080
dei City Area Code
CityAreaCode
925
dei Local Phone Number
LocalPhoneNumber
407-1049
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
NKTX
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
49058234
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29117000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37494000
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
251636000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
314649000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5983000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8545000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
286736000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
360688000
CY2023Q2 us-gaap Long Term Investments
LongTermInvestments
18728000
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2743000
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2743000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
76094000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
61908000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
41071000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
45749000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3666000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1850000
CY2023Q2 us-gaap Assets
Assets
429038000
CY2022Q4 us-gaap Assets
Assets
472938000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3010000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1761000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6050000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4249000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
17553000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
16036000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-33287000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-26923000
us-gaap Net Income Loss
NetIncomeLoss
-64102000
us-gaap Net Income Loss
NetIncomeLoss
-52910000
CY2023Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-427000
CY2022Q2 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-325000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
78000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-781000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-33714000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-27248000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
26613000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
22046000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
84447000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
78685000
CY2023Q2 us-gaap Liabilities
Liabilities
111060000
CY2022Q4 us-gaap Liabilities
Liabilities
100731000
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
5000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
5000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
700609000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
690814000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-601000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-679000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-382035000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-317933000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
317978000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
372207000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
429038000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
472938000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25122000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21049000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
51257000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
40617000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11736000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6563000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
19914000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13093000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
36858000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
27612000
us-gaap Operating Expenses
OperatingExpenses
71171000
us-gaap Operating Expenses
OperatingExpenses
53710000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-36858000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-27612000
us-gaap Operating Income Loss
OperatingIncomeLoss
-71171000
us-gaap Operating Income Loss
OperatingIncomeLoss
-53710000
CY2023Q2 us-gaap Investment Income Net
InvestmentIncomeNet
3570000
CY2022Q2 us-gaap Investment Income Net
InvestmentIncomeNet
686000
us-gaap Investment Income Net
InvestmentIncomeNet
7035000
us-gaap Investment Income Net
InvestmentIncomeNet
798000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
34000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3571000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
689000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
7069000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
800000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-64024000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-53691000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.38
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48970391
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48970391
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43841392
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43841392
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48946018
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48946018
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38446956
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38446956
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
372207000
CY2023Q1 nktx Stock Issued During Period Value Vesting Of Shares Of Common Stock Subject To Repurchase
StockIssuedDuringPeriodValueVestingOfSharesOfCommonStockSubjectToRepurchase
2000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4746000
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
505000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-30815000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
346646000
CY2023Q2 nktx Stock Issued During Period Value Vesting Of Shares Of Common Stock Subject To Repurchase
StockIssuedDuringPeriodValueVestingOfSharesOfCommonStockSubjectToRepurchase
1000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
21000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
374000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4650000
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-427000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-33287000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
317978000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
250967000
CY2022Q1 nktx Stock Issued During Period Value Vesting Of Shares Of Common Stock Subject To Repurchase
StockIssuedDuringPeriodValueVestingOfSharesOfCommonStockSubjectToRepurchase
6000
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
79000
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4097000
CY2022Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-456000
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-25987000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
228706000
CY2022Q2 nktx Stock Issued During Period Value Vesting Of Shares Of Common Stock Subject To Repurchase
StockIssuedDuringPeriodValueVestingOfSharesOfCommonStockSubjectToRepurchase
3000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
334000
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
215334000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3912000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-325000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-26923000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
421041000
us-gaap Profit Loss
ProfitLoss
-64102000
us-gaap Profit Loss
ProfitLoss
-52910000
us-gaap Share Based Compensation
ShareBasedCompensation
9396000
us-gaap Share Based Compensation
ShareBasedCompensation
8009000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1636000
us-gaap Net Income Loss
NetIncomeLoss
-52910000
CY2023Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
48970457
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1243000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
4511000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1110000
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
34000
us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
4100000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1100000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2019000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-663000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3282000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
7143000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
3649000
nktx Increase Decrease In Accounts Payable And Accrued And Other Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedAndOtherLiabilities
2078000
nktx Increase Decrease In Accounts Payable And Accrued And Other Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedAndOtherLiabilities
-1274000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-42531000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-34872000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15151000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4399000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
157486000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
175011000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
206395000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
69088000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
33758000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-110322000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
22000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
413000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
374000
nktx Proceeds From Secondary Offering Net Of Issuance Costs
ProceedsFromSecondaryOfferingNetOfIssuanceCosts
215611000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
396000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
216024000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8377000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
70830000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
40237000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
62914000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
31860000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
133744000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29117000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
131646000
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
2743000
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
2098000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
31860000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
133744000
nktx Noncash Or Part Noncash Acquisition Fixed Assets Acquired Included In Accounts Payable
NoncashOrPartNoncashAcquisitionFixedAssetsAcquiredIncludedInAccountsPayable
690000
nktx Noncash Or Part Noncash Acquisition Fixed Assets Acquired Included In Accounts Payable
NoncashOrPartNoncashAcquisitionFixedAssetsAcquiredIncludedInAccountsPayable
926000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-382000000
CY2023Q2 nktx Cash Cash Equivalents Restricted Cash And Short Term Investments
CashCashEquivalentsRestrictedCashAndShortTermInvestments
302200000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the Company’s financial statements and accompanying notes. On an ongoing basis, management evaluates its estimates, including those related to preclinical studies, fair value of assets and liabilities, impairment of assets, leases, share-based compensation and income taxes. Management bases its estimates on historical experience, knowledge of current events and actions it may undertake in the future that management believes to be reasonable under the circumstances. Actual results may differ from these estimates and assumptions.</span></p>
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-33287000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-26923000
us-gaap Net Income Loss
NetIncomeLoss
-64102000
CY2022Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
43844869
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
48946131
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
38452511
CY2023Q2 nktx Weighted Average Number Of Shares Unvested Common Stock Issued Upon Early Exercise Of Common Stock Options
WeightedAverageNumberOfSharesUnvestedCommonStockIssuedUponEarlyExerciseOfCommonStockOptions
-66
CY2022Q2 nktx Weighted Average Number Of Shares Unvested Common Stock Issued Upon Early Exercise Of Common Stock Options
WeightedAverageNumberOfSharesUnvestedCommonStockIssuedUponEarlyExerciseOfCommonStockOptions
-3477
nktx Weighted Average Number Of Shares Unvested Common Stock Issued Upon Early Exercise Of Common Stock Options
WeightedAverageNumberOfSharesUnvestedCommonStockIssuedUponEarlyExerciseOfCommonStockOptions
-113
nktx Weighted Average Number Of Shares Unvested Common Stock Issued Upon Early Exercise Of Common Stock Options
WeightedAverageNumberOfSharesUnvestedCommonStockIssuedUponEarlyExerciseOfCommonStockOptions
-5555
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48970391
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48970391
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43841392
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43841392
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
48946018
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
48946018
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
38446956
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38446956
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.68
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.68
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.61
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.61
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.31
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.38
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7474785
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5580507
CY2023Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
27893000
CY2023Q2 us-gaap Short Term Investments
ShortTermInvestments
251636000
CY2023Q2 us-gaap Long Term Investments
LongTermInvestments
18728000
CY2023Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
298257000
CY2022Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
36494000
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
314649000
CY2022Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
351143000
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
270965000
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
612000
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
11000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
270364000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
315328000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
762000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
83000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
314649000
us-gaap Debt Securities Available For Sale Realized Gain Loss
DebtSecuritiesAvailableForSaleRealizedGainLoss
0
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
3390000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
5616000
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
2593000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2929000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5983000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8545000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
83554000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
67732000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7460000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
5824000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
76094000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
61908000
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
800000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1600000
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
600000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1200000
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4930000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6691000
CY2023Q2 nktx Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
6338000
CY2022Q4 nktx Accrued Research And Development Costs Current
AccruedResearchAndDevelopmentCostsCurrent
3486000
CY2023Q2 nktx Accrued Property And Equipment Liabilities Current
AccruedPropertyAndEquipmentLiabilitiesCurrent
5689000
CY2022Q4 nktx Accrued Property And Equipment Liabilities Current
AccruedPropertyAndEquipmentLiabilitiesCurrent
5001000
CY2023Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
596000
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
858000
CY2023Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
17553000
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
16036000
CY2023Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
2700000
us-gaap Operating Lease Expense
OperatingLeaseExpense
5500000
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
2800000
us-gaap Operating Lease Expense
OperatingLeaseExpense
5400000
us-gaap Proceeds From Lease Payments
ProceedsFromLeasePayments
2800000
us-gaap Proceeds From Lease Payments
ProceedsFromLeasePayments
200000
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
7800000
us-gaap Payments For Proceeds From Tenant Allowance
PaymentsForProceedsFromTenantAllowance
2100000
us-gaap Operating Lease Payments
OperatingLeasePayments
5000000
us-gaap Operating Lease Payments
OperatingLeasePayments
1900000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y3M18D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0974
CY2021Q3 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P12Y
CY2021Q3 nktx Cash Received For Tenant Improvement Allowances To Be Repaid
CashReceivedForTenantImprovementAllowancesToBeRepaid
4400000
CY2023Q2 nktx Cash Received For Tenant Improvement Allowances To Be Repaid
CashReceivedForTenantImprovementAllowancesToBeRepaid
4400000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
6560000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
12720000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
13027000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
13462000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
13912000
CY2023Q2 nktx Lessee Operating Lease Liability Payments Due Year Five And Thereafter
LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereafter
87254000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
146935000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
56438000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
90497000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6050000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
84447000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
90497000
CY2023Q2 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
4100000
CY2023Q2 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
0
CY2022Q4 us-gaap Guarantee Obligations Current Carrying Value
GuaranteeObligationsCurrentCarryingValue
0
nktx Contingency Loss Recorded
ContingencyLossRecorded
0
nktx Provision For Loss Contingency
ProvisionForLossContingency
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.14
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
4650000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3912000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9396000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8009000
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
29300000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M1D
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0

Files In Submission

Name View Source Status
0000950170-23-040953-index-headers.html Edgar Link pending
0000950170-23-040953-index.html Edgar Link pending
0000950170-23-040953.txt Edgar Link pending
0000950170-23-040953-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img34246019_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
nktx-20230630.htm Edgar Link pending
nktx-20230630.xsd Edgar Link pending
nktx-ex10_1.htm Edgar Link pending
nktx-ex10_2b.htm Edgar Link pending
nktx-ex31_1.htm Edgar Link pending
nktx-ex31_2.htm Edgar Link pending
nktx-ex32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
nktx-20230630_cal.xml Edgar Link unprocessable
nktx-20230630_def.xml Edgar Link unprocessable
nktx-20230630_lab.xml Edgar Link unprocessable
nktx-20230630_pre.xml Edgar Link unprocessable
nktx-20230630_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable